An tOrd Gnó (Atógáil) - Order of Business (Resumed)
Dail Éireann — 2026-06-09
============================================================

Micheál Martin (FF), Cork South-Central

I thank the Deputy for raising the issue. I will very quickly go through it because I think he is looking for clarification. Basically, the HSE received an application for pricing and reimbursement on 1 August 2024 for Skyclarys, for adults and adolescents aged 16 years and older. On foot of a rapid review of the application by the National Centre for Pharmacoeconomics, the HSE commissioned a full health technology assessment, HTA, on 25 September 2024. Necessary materials were submitted by Biogen Idec on 2 July 2025, ten months after the HTA was commissioned by the HSE. The agency met with Biogen Idec on 12 February. However, despite several requests, a commercial proposal from the applicant was not received until 28 May. This is the information that I have available.
That said, we need to get this decided upon as quickly as we possibly can. My understanding is it would be on the agenda for the July meeting of the HSE's drugs group, but if we can bring it forward, we will, although I do not want to make any commitments on that.
However, there are many families out there who are very worried and stressed. I acknowledge that.

---

Source: Houses of the Oireachtas. Licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). The Official Report is revised after first publication; the fetch timestamp below identifies the version quoted.

Record URI: https://data.oireachtas.ie/akn/ie/debateRecord/dail/2026-06-09/debate/main
Retrieved: 2026-09-14T01:01:05+00:00
Sitting date: 2026-06-09